Led by UNSW Medicine and funded by the Cancer Theme and (Maridulu Budyari Gumal [SPHERE] Cancer CAG), the workshop enabled experts across all steps of drug development and the SPHERE partnership to explore ideas around commercialising research into treatments, therapies or drugs to improve health across the community.
Leader of the Translational Cancer Metabolism Laboratory in the Adult Cancer Program at UNSW, A/Prof Jeff Holst explained, “The take home message reiterated by many speakers was that we need to fail fast by doing the right commercial grade assays early in our drug development pipeline. This will save time and money and ensure we develop the best drug candidate.”
A video of the entire workshop is available here, including a handy shortcut table to take you to the speaker or section you want to view.
News about the workshop can be accessed here.